Skip to main content
. 2009 Oct 20;101(10):1709–1716. doi: 10.1038/sj.bjc.6605375

Figure 6.

Figure 6

Requirement of CD8+ T cells for therapeutic efficacy of B7-H3 blockade. The tumour size between the control group and the treatment group did not have any statistical difference at 4 weeks after tumour implantation in mice depleted of CD8+ T cells.